
Captiva ES 40mg Injection
Marketer
Ridhima Biocare
Salt Composition
Esomeprazole (40mg)
Overview Captiva ES 40mg Injection
Injex 40mg is a medication that diminishes gastric acid secretion. It's indicated for treating acid-related gastrointestinal disorders, including acid reflux and other conditions stemming from excessive stomach acid. Injex 40mg is also used prophylactically against stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this intravenous medication is administered by a healthcare provider only when deemed clinically superior to oral forms. Dosage and treatment duration are determined individually based on patient response and condition. Lifestyle modifications, such as consuming smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods, can enhance treatment effectiveness. Common adverse events include injection site reactions, nausea, headache, dizziness, flatulence, diarrhea, abdominal pain, and fundic gland polyps. While generally mild, persistent or bothersome symptoms warrant medical attention. Discuss bone loss prevention strategies, such as calcium and vitamin D supplementation, with your physician. Injex 40mg is contraindicated in certain individuals. Prior to administration, inform your doctor of any severe hepatic impairment, concomitant HIV medications, prior allergic reactions to similar drugs, or pre-existing osteoporosis. Pregnant or lactating women should seek medical advice. Alcohol consumption should be avoided due to its potential to exacerbate gastric acid production and worsen symptoms.
Uses of Captiva ES 40mg Injection
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Captiva ES 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Captiva ES 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Captiva ES 40mg Injection:
This medication will be administered by your physician or their designated nursing staff; self-medication is strictly prohibited.
How Captiva ES 40mg Injection works:
Stomach acid production is decreased by the proton pump inhibitor Captiva ES 40mg Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while using Captiva ES 40mg Injection. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Captiva ES 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential benefits against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administration of Captiva ES 40mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Captiva ES 40mg Injection on driving ability is undetermined. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
For individuals with severely impaired kidney function, administering Captiva ES 40mg Injection requires careful consideration and potential dose modification. Patients with mild to moderate kidney impairment do not necessitate dosage changes. Physician consultation is recommended.
LiverCAUTION
For patients with severe hepatic impairment, administering Captiva ES 40mg Injection requires careful consideration and potential dosage modification. Individuals with mild to moderate liver disease do not necessitate dosage alteration. Physician consultation is advised.
What if you forget to take Captiva ES 40mg Injection :
Should you forget a dose of Captiva ES 40mg Injection, seek your physician's advice.
Facts to Know About Captiva ES 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Type of Treatment | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
